SBStephan Budweiser

Stephan Budweiser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephan Budweiser has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Pfeifer

    Center for Pneumology, Donaustauf Hospital, Donaustauf, Germany ; Department of Internal Medicine II, Division of Respirology, University of Regensburg, Regensburg, Germany

    13 shared publications
  • Rudolf A. Jörres

    Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilian University, Munich, Germany

    9 shared publications
  • Frank Heinemann

    8 shared publications
  • M. Pfeifer

    Centre for Pneumology; Donaustauf Hospital; Ludwigstrasse 68 Donaustauf Germany

    4 shared publications
  • R. A. Jörres

    Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine; Ludwig-Maximilians-University; Munich Germany

    4 shared publications
  • André P. Hitzl

    3 shared publications

Latest Publications

  • Open Access

    Lung function and associations with multiple dimensions of dental health: a prospective observational cross-sectional study

    by Christian Henke, Stephan Budweiser, Rudolf A. Jörres

    Epidemiological data suggest an association between respiratory diseases and periodontal health. However, the link between the overall dental status and single lung function measures, within a practical clinical context, is not well studied. Following a prospective cross-sectional design, consecutive adult patients were evaluated. Next to spirometry, anthropometric data, profession, smoking status, symptoms, self-rated exercise performance, comorbidities, allergies and medication were determined. Assessment of dental status comprised carious lesions, dental fillings, missing teeth, dentures, insufficient fillings/dentures, implants, oral mucosa diseases, calculus, decayed-missed-filling-teeth (DMF-T)-index, periodontal screening-index, and orthopantomograms. Among 587 adult patients considered, 206 were included (119 female; median age 42.0 years; 56 % smoking history). Most patients had dental fillings (86.9 %), fix/mobile dentures (66.5 %), missing teeth (56.8 %) and calculus (84.0 %), the overall DMF-T being 15 (9; 21). Periodontitis was present in 53.9 %, an abnormal orthopanthomogram in 47.9 % of subjects. Regarding spirometric indices expressed as % predicted, dentures, missing teeth, oral mucosal diseases and a DMF-T > 15 (median) were associated with lower maximal expiratory flows at 25 % of vital capacity (MEF25) (p < 0.05 each). In adjusted logistic regression analyses, only dentures were associated with low MEF25 % predicted and with the ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC; p < 0.05 each). However, periodontitis and DMF-T were linked to age (p < 0.001) and packyears (p < 0.05) only. Within a real-life clinical setting, only the presence of dentures showed weak associations with lung function, suggesting small airways dysfunction and obstruction. Most of the associations were explained by smoking habits and age.


  • Open Access

    Mental health, serum biomarkers and survival in severe COPD: a pilot study

    by Christian Zilz, Stefan H. Blaas, Michael Pfeifer, Rudolf A. Jörres, Stephan Budweiser

    Chronic obstructive pulmonary disease (COPD) impairs physical status and impacts on mental health. This prospective study was designed to assess associations between mental health and systemic biomarkers, and their combined relationship with long-term survival in stable severe COPD. Forty-five patients with severe but stable COPD (forced expiratory volume in 1 s of 29.8 (quartiles: 22.6; 41.4) %predicted) were assessed using the Hospital Anxiety and Depression Scale (HADS), the Patient Health Questionnaire (PHQ), St. George’s Respiratory Questionnaire and the State-Trait Anxiety Inventory (STAI). The following serum biomarkers were measured: 25-OH-cholecalciferol, C-reactive protein, erythrocyte sedimentation rate, leucocyte number, serum amyloid-A (SA-A), N-terminal pro-brain natriuretic peptide, troponin I, glycosylated haemoglobin, haemoglobin (Hb), haematocrit (Hc), creatinine and thyroid-stimulating hormone. Patients were followed-up for 36 months. Associations between aspects of mental health and biomarkers, and their utility as predictors of 3-year survival were evaluated by regression analyses. The prevalence of anxiety (HADS-A: 89.9 %), depression (HADS-D: 58.8 %; PHQ: 60.6 %), somatisation (PHQ-15: 81.8 %) and psychosocial stress (PHQ-stress: 60.6 %) was high. There was a significant positive association between the leucocyte count and SA-A level with STAI-trait anxiety (p = 0.03 and p = 0.005, respectively), and between leucocytes and PHQ-stress (p = 0.043). Hb and Hc were significantly negatively associated with HADS-depression (p = 0.041 and p = 0.031, respectively). Univariate Cox regression analyses revealed that leucocyte count (hazard ratio (HR) 2.976, 95 % CI 1.059-8.358; p = 0.038), and stress (HR 4.922, 95 % CI 1.06–22.848; p = 0.042) were linked to long-term survival. In multivariate Cox regression analyses, including known risk factors for survival in COPD, PHQ-stress (HR 45.63, 95 % CI 1.72–1,208.48; p = 0.022) remained significantly associated with survival. In this pilot study different dimensions of mental health were correlated to serum biomarkers, probably reflecting systemic effects of COPD. While leucocyte number and PHQ-stress were associated with long-term survival in univariate analyses, PHQ-stress remained in multivariate analyses as independent prognostic factor.


  • The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure

    by R. Schneckenpointner, R. A. Jörres, N. Meidenbauer, F. Kollert, M. Pfeifer, S. Budweiser

    Anaemia is a frequent, clinically relevant condition in various chronic diseases. It seems also to be prevalent in patients with chronic respiratory failure (CRF). We studied the characteristics of anaemia in CRF and its associations with clinical outcome. In a prospective design, 271 consecutive patients with CRF were evaluated; patients with other conditions often associated with anaemia were excluded. Haematological laboratory and physiological parameters, health-related quality of life (HRQL), dyspnoea and 48-month survival were determined. Anaemia was defined according to WHO [haemoglobin (Hb)< 13 g/l (male); Hb< 12 g/dl (female)] and using an established algorithm. Among 185 patients included, 18.4% showed anaemia, not depending on chronic obstructive pulmonary disease (COPD) vs. non-COPD (17.6% vs. 19.0%; p = 0.851) or on gender [16.5% (female) vs. 19.8% (male); p = 0.702]. Anaemic patients had higher age, creatinine (p < 0.05 each) and erythropoietin levels (p < 0.001), but lower transferrin saturation (TSAT), serum iron and vitamin B12 levels (p < 0.01 each). By definition, most anaemic patients (67.6%) had disturbances in iron homeostasis according to 'anaemia of chronic disease' and/or true iron deficiency anaemia. Hb was independently related to dyspnoea and HRQL, while TSAT ≥ 20% was linked to less dyspnoea and better subjective exercise capability. Non-survivors had lower Hb and serum iron levels (p < 0.05 each). In multivariate analysis, lower serum iron levels and TSAT were independently associated with mortality (p < 0.05 each). Anaemia was common in patients with CRF and often because of disturbed iron homeostasis. Hb and TSAT were linked to functional outcome and HRQL. Lower serum iron levels and TSAT were independent prognostic parameters.


  • Sleep Apnea is an Independent Correlate of Erectile and Sexual Dysfunction

    by Stephan Budweiser, Stefan Enderlein, Rudolf A. Jörres, Andre P. Hitzl, Wolf F. Wieland, Michael Pfeifer, Michael Arzt

    Introduction: Obstructive sleep apnea (OSA) has been linked with erectile dysfunction (ED), but it is unknown whether this association is maintained in the presence of other risk factors for ED. Aim: The aim of this study was to evaluate the relationship between ED/sexual dysfunction and polysomnographic measures of sleep apnea in patients with known risk factors for ED. Methods: Prospective cross-sectional analysis of 401 male patients undergoing in-lab polysomnography for suspected OSA. Erectile (EF) and sexual function were assessed by the 15-item International Index of Erectile Function (IIEF-15) questionnaire. Main Outcome Measures: Severity of OSA via apnea–hypopnea index (AHI) and mean/lowest nocturnal oxygen saturation (SaO2). The IIEF-15 including the sexual domains: EF, intercourse satisfaction, orgasmic function, sexual desire, and overall satisfaction. Results: OSA (AHI > 5/h) was diagnosed in 92% of patients. ED (EF subdomain ≤ 25) was present in 69% of patients with, and 34% of patients without OSA (P < 0.001). Multivariate stepwise regression analyses including known risk factors for ED, such as age, obesity, coronary heart disease, peripheral occlusive disease, hypertension, diabetes, prostate surgery, and β-blocker treatment, and measures of sleep apnea identified mean nocturnal SaO2 as independently associated with ED (P = 0.002; mean [95% CI] normalized slope 0.126 [0.047; 0.205]). Age (P < 0.001), peripheral occlusive disease (P = 0.001), prostate surgery (P = 0.018), and hypertension (P = 0.021) were confirmed as risk factors for ED, but did not abolish the sleep apnea-associated risk. Similar results were obtained for sexual dysfunction. Logistic regression analysis using the diagnosis of ED (EF subdomain ≤ 25) as binary dependent variable confirmed that mean nocturnal SaO2 (P = 0.012), as well as age (P < 0.001) were independently associated with ED. Conclusions: ED and overall sexual dysfunction were highly prevalent in patients with suspected OSA. Irrespective of known risk factors, mean nocturnal SaO2 was an additional, independent correlate of these dysfunctions, suggesting that OSA-related intermittent nocturnal hypoxemia specifically contributes to their development.


  • Prognosefaktoren bei Patienten mit COPD mit chronisch-hyperkapnischer respiratorischer Insuffizienz und außerklinischer Beatmungstherapie

    by S. Budweiser, R. A. Jörres, F. Heinemann, M. Pfeifer

    Die Prävalenz der Patienten mit schwerer COPD und chronisch hyperkapnischer respiratorischer Insuffizienz (CHRI), die einer außerklinischen Beatmung zugeführt werden, hat erheblich zugenommen. Im Hinblick auf die Schwere der Erkrankung erscheint eine multidimensionale Betrachtung sinnvoll. Der Basenüberschuss (BE) reflektiert die langfristige metabolische Kompensation der chronischen Hyperkapnie und stellt einen vielversprechenden, leicht fassbaren und integrativen Parameter der CHRI dar. Dieser konnte zusätzlich zu Ernährungsstatus und Lungenüberblähung als unabhängiger Prädiktor des Langzeitüberlebens detektiert werden. Darüber hinaus sind in Zusammenschau mit der Literatur sowohl zur Krankheitseinschätzung als zur Verlaufsbeurteilung weitere Marker sowie häufige Komorbiditäten zu berücksichtigen. Dementsprechend sollte auch die Entscheidung für eine außerklinische Beatmung nicht nur auf der Basis von Symptomen bzw. der chronischen Hyperkapnie erfolgen, sondern auch Faktoren einbeziehen, welche die Schwere der Erkrankung in spezifischer Weise abbilden. Retrospektive Daten deuten zudem daraufhin, dass auch COPD-Patienten mit wiederholten hyperkapnischen Dekompensationen oder nach prolongierter Beatmungsentwöhnung für eine außerklinische Beatmung infrage kommen. Dies ist allerdings noch in prospektiven Studien weiter zu evaluieren. The prevalence of patients with severe COPD and chronic hypercapnic respiratory failure (CHRF) receiving non-invasive home ventilation has greatly increased. With regard to disease severity, a multidimensional assessment seems indicated. Base excess (BE), in particular, reflects the long-term metabolic response to chronic hypercapnia and thus constitutes a promising, easily accessible, integrative marker of CHRF. Infact, BE as well as nutritional status and lung hyperinflation have been identified as independent predictors of long-term survival. In addition and in a review with the literature, a broad panel of indices including frequent comorbidities are helpful for assessment and monitoring purposes of patients with CHRF. Accordingly, in view of the patients' individual risk profile, the decision about the initiation of NIV should probably not rely solely on symptoms and chronic persistent hypercapnia but include a spectrum of factors that specifically reflect disease severity. Owing to the physiologically positive effects of NIV and according to retrospective data, patients with COPD and recurrent hypercapnic respiratory decompensation and patients with prolonged mechanical ventilation and/or difficult weaning could also be considered for long-term non-invasive ventilation. This, however, has to be corroborated in future prospective trials.


  • Open Access

    Treatment of respiratory failure in COPD

    by Stephan Budweiser, Rudolf A Jörres, Michael Pfeifer

    Treatment of respiratory failure in COPD Stephan Budweiser1, Rudolf A Jörres2, Michael Pfeifer1,31Center for Pneumology, Hospital Donaustauf, Donaustauf, Germany; 2Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University, Munich, Germany; 3Department of Internal Medicine II, Division of Respirology, University of Regensburg, Regensburg, Germany Patients with advanced COPD and acute or chronic respiratory failure are at high risk for death. Beyond pharmacological treatment, supplemental oxygen and mechanical ventilation are major treatment options. This review describes the physiological concepts underlying respiratory failure and its therapy, as well as important treatment outcomes. The rationale for the controlled supply of oxygen in acute hypoxic respiratory failure is undisputed. There is also a clear survival benefit from long-term oxygen therapy in patients with chronic hypoxia, while in mild, nocturnal, or exercise-induced hypoxemia such long-term benefi ts appear questionable. Furthermore, much evidence supports the use of non-invasive positive pressure ventilation in acute hypercapnic respiratory failure. It application reduces intubation and mortality rates, and the duration of intensive care unit or hospital stays, particularly in the presence of mild to moderate respiratory acidosis. COPD with chronic hypercapnic respiratory failure became a major indication for domiciliary mechanical ventilation, based on pathophysiological reasoning and on data regarding symptoms and quality of life. Still, however, its relevance for long-term survival has to be substantiated in prospective controlled studies. Such studies might preferentially recruit patients with repeated hypercapnic decompensation or a high risk for death, while ensuring effective ventilation and the patientsâ?? adherence to therapy.Keywords: respiratory failure, COPD, mechanical ventilation, non-invasive ventilation long-term oxygen therapy, chronic hypercapnic respiratory failure, oxygen


  • Noninvasive home ventilation for chronic obstructive pulmonary disease: indications, utility and outcome

    by Stephan Budweiser, Rudolf A Jörres, Michael Pfeifer

    Despite its widespread use, the role of noninvasive home mechanical ventilation for the management of severe chronic obstructive pulmonary disease and chronic hypercapnic respiratory failure is still controversial. The majority of randomized controlled trials show methodological weaknesses, including issues of patient selection, insufficient pressure support and poor adherence to therapy. Data from short-term trials, while assuring effective ventilation, are encouraging by demonstrating physiological improvements, in line with benefits regarding symptoms and quality of life. The role of home mechanical ventilation for long-term survival is, however, still unclear. Possible indications of home mechanical ventilation, physiological concepts underlying the effects of noninvasive ventilation and their impact on clinically important long-term outcomes are reported. Due to systemic involvement, the decision to undertake home mechanical ventilation should probably not be based on symptomatic chronic hypercapnia alone, but on a broader spectrum of factors. In particular, patients with repeated hypercapnic decompensation are at high risk for death and obvious candidates for home mechanical ventilation. Beyond restoration of chemosensitivity, changes in breathing pattern and a reduction of mechanical load are likely mechanisms of home mechanical ventilation, inducing symptom relief and improving functional reserve. To fully utilize its potential, high pressure levels are required. Future prospective controlled studies should take into account these experiences.


  • Body Mass Index in COPD Mortality: Response

    by Stephan Budweiser, Rudolf A. Jörres

  • Open Access

    Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis

    by Stephan Budweiser, Andre P Hitzl, Rudolf A Jörres, Kathrin Schmidbauer, Frank Heinemann, Michael Pfeifer

    Health-related quality of life (HRQL) is considered as an important outcome parameter in patients with chronic diseases. This study aimed to assess the role of disease-specific HRQL for long-term survival in patients of different diagnoses with chronic hypercapnic respiratory failure (CHRF).